We’ll dive into the neurobiology of nicotine addiction in individuals with serious mental illness (SMI), review promising evidence-based interventions and discuss how tobacco treatment can be effectively integrated into psychiatric and behavioral health systems. We’ll also examine the epidemiological landscape, unpack misconceptions that hinder progress, and highlight population-specific considerations to ensure fair access to care. This session will support clinicians, public health professionals and behavioral health leaders in advancing tobacco-free recovery.

Learning Objectives: By the end of this webinar, participants will be able to:

1. Describe the impact of tobacco use and nicotine addiction among individuals with serious mental illness and its public health impact. 2. Identify common myths, biases, and barriers that contribute to disparities in tobacco treatment within psychiatric settings.
3. Explain the neurobiological mechanisms that make individuals with SMI more vulnerable to nicotine dependence.
4. Discuss promising interventions and strategies for treating tobacco use among individuals with SMI, including pharmacologic and behavioral approaches.
5. Explain models/strategies for integrating tobacco treatment into mental health and psychiatric care systems to support long-term recovery and health disparities.

Participants who join the live session can earn one hour of free credit. You will receive instructions on how to claim credit via the post-webinar email. Don’t need to claim CME/CEUs? SCLC also issues free certificates of attendance for those who want contact hours only.